-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on Agilon Health, Raises Price Target to $13

Benzinga·04/02/2026 16:12:49
Listen to the news
Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and raises the price target from $1.5 to $13.